Literature DB >> 11597661

Vascular calcification in chronic renal failure.

W G Goodman1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11597661     DOI： 10.1016/S0140-6736(01)06299-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  15 in total

Review 1.  Benefits and harm of niacin and its analog for renal dialysis patients: a systematic review and meta-analysis.

Authors:  Yuan-Mei He; Li Feng; Dong-Mei Huo; Zhen-Hua Yang; Yun-Hua Liao
Journal:  Int Urol Nephrol       Date:  2013-10-11       Impact factor: 2.370

Review 2.  Molecular imaging insights into early inflammatory stages of arterial and aortic valve calcification.

Authors:  Sophie E P New; Elena Aikawa
Journal:  Circ Res       Date:  2011-05-27       Impact factor: 17.367

3.  Longitudinal relationships among coronary artery calcification, serum phosphorus, and kidney function.

Authors:  Katherine R Tuttle; Robert A Short
Journal:  Clin J Am Soc Nephrol       Date:  2009-11-05       Impact factor: 8.237

4.  Cardiovascular calcifications in pediatric patients receiving maintenance dialysis.

Authors:  Rita D Sheth; Maria D Perez; Stuart L Goldstein
Journal:  Pediatr Nephrol       Date:  2003-05-28       Impact factor: 3.714

Review 5.  Lanthanum carbonate: a review of its use in lowering serum phosphate in patients with end-stage renal disease.

Authors:  Monique P Curran; Dean M Robinson
Journal:  Drugs       Date:  2009-11-12       Impact factor: 9.546

6.  Pre-treatment of dairy and breast milk with sevelamer hydrochloride and sevelamer carbonate to reduce phosphate.

Authors:  Renske Raaijmakers; Lambertus M W Houkes; Cornelis H Schröder; Johannes L Willems; Leo A H Monnens
Journal:  Perit Dial Int       Date:  2013-05-01       Impact factor: 1.756

7.  Sevelamer hydrochloride: an effective phosphate binder in dialyzed children.

Authors:  Homa Mahdavi; Beatriz D Kuizon; Barbara Gales; He-Jing Wang; Robert M Elashoff; Isidro B Salusky
Journal:  Pediatr Nephrol       Date:  2003-10-30       Impact factor: 3.714

8.  Short-term treatment with sevelamer increases serum fetuin-a concentration and improves endothelial dysfunction in chronic kidney disease stage 4 patients.

Authors:  Kayser Caglar; Mahmut Ilker Yilmaz; Mutlu Saglam; Erdinc Cakir; Cengizhan Acikel; Tayfun Eyileten; Mujdat Yenicesu; Yusuf Oguz; Abdulgaffar Vural; Juan Jesus Carrero; Jonas Axelsson; Bengt Lindholm; Peter Stenvinkel
Journal:  Clin J Am Soc Nephrol       Date:  2007-12-05       Impact factor: 8.237

9.  Arterial and aortic valve calcification abolished by elastolytic cathepsin S deficiency in chronic renal disease.

Authors:  Elena Aikawa; Masanori Aikawa; Peter Libby; Jose-Luiz Figueiredo; Gabriel Rusanescu; Yoshiko Iwamoto; Daiju Fukuda; Rainer H Kohler; Guo-Ping Shi; Farouc A Jaffer; Ralph Weissleder
Journal:  Circulation       Date:  2009-03-23       Impact factor: 29.690

10.  Phosphate binding therapy in dialysis patients: focus on lanthanum carbonate.

Authors:  Ismail A Mohammed; Alastair J Hutchison
Journal:  Ther Clin Risk Manag       Date:  2008-10       Impact factor: 2.423
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.